Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Perihilar Intraductal Papillary Neoplasm of the Bile Ducts: A Clinicopathologic and Molecular Genetic Study of 27 Cases
PRODUCTS USED
ABSTRACT
The College of American Pathologists recognizes intraductal papillary neoplasm of the bile ducts (IPNB) with an associated invasive carcinoma in its protocols for the pancreas and intrahepatic bile ducts, but not for the perihilar or distal bile ducts. We aimed to investigate the clinicopathologic and molecular features of 27 surgically resected perihilar IPNB cases. The cohort included 14 males and 13 females, with a median age of 70 years. Six IPNBs were noninvasive, while 21 had associated invasive carcinoma. The median overall tumor size was 2.8 cm, and the median invasive tumor size was 1.2 cm. Eight of 16 patients had elevated CA19-9. Immunohistochemistry as a surrogate of molecular analysis was performed in 19 cases with invasive carcinoma. Among them, positive PD-L1 expression was found in 3 cases (15.8%, all had low expression, CPS